arrow
A

Aida Niñerola-Baizán

University of Barcelona
H指数:15
被引数:1,073

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Biomarkers of neurodegenerative parkinsonisms: From current clinical to future biological definitions - literature review and our experience

神经退行性帕金森综合征的生物标志物:从当前临床到未来生物学定义——文献综述及我们的经验

2025-04-291
PRE
Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy
2024-03-1113
OAAI
Impact of simulated reduced injected dose on the assessment of amyloid PET scans

模拟减少注射剂量对淀粉样蛋白PET扫描评估的影响

2023-10-280
OAAI
APOE-ε4 modulates the association between regional amyloid deposition and cognitive performance in cognitively unimpaired middle-aged individuals
2023-03-012
OAAI
Reactive astrogliosis is associated with higher cerebral glucose consumption in the early Alzheimer's continuum
2022-07-1819
OAAI
Brain alterations in the early Alzheimer's continuum with amyloid-β, tau, glial and neurodegeneration CSF markers
2022-05-2422
OAAI
CSF Synaptic Biomarkers in the Preclinical Stage of Alzheimer Disease and Their Association With MRI and PET A Cross-sectional Study
2021-11-2346
OAAI
Cognitively unimpaired individuals with a low burden of Aβ pathology have a distinct CSF biomarker profile
2021-07-2712
OAAI
Cerebral amyloid-β load is associated with neurodegeneration and gliosis: Mediation by p-tau and interactions with risk factors early in the Alzheimer's continuum
2021-03-0418
OA
Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent

[18F]flutemetamol PET图像的视觉评估可以检测早期淀粉样蛋白病理并对其程度进行分级

2021-02-2231
OAAI
Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer's disease
2021-02-1712
OAAI
Quantitative informant- and self-reports of subjective cognitive decline predict amyloid beta PET outcomes in cognitively unimpaired individuals independently of age and APOE ε4

主观认知能力下降的定量信息和自我报告可预测认知未受损个体的淀粉样 β PET结局,而与年龄和apoeε4无关

2020-11-1111
OAAI